Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 3

1(16.7%)

6Total

N/A(5)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05899114Not ApplicableActive Not Recruiting

Less Is More: Optimized Pharmacotherapy With Improved coNtinuity of CarE in hospitaLized oLder peOple

Role: collaborator

NCT06066385Not ApplicableUnknown

Suture Techniques to Reduce the Incidence of Incisional Hernia: LTFU STITCH Trial

Role: collaborator

NCT03833531Not ApplicableCompleted

Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and CPD

Role: collaborator

NCT03309683Not ApplicableCompleted

Clip Placement Following Colonic Endoscopic Mucosal Resection (EMR)

Role: collaborator

NCT05064917Unknown

BAT Cow's Milk for the Replacement of the Food Challenge Test

Role: collaborator

NCT03833453Not ApplicableUnknown

Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and BPD

Role: collaborator

NCT02669459Phase 3Unknown

Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol

Role: collaborator

All 7 trials loaded